Ocular immunosuppressive microenvironment.
Taylor
A W
AW
Schepens Eye Research Institute, Harvard Medical School, Boston, Mass., USA. awtaylor@vision.eri.harvard.edu
D000818:Animals; D017951:Antigen Presentation; D001082:Aqueous Humor / Q000276:immunology; D018916:Blood-Aqueous Barrier; D001813:Blood-Retinal Barrier; D015740:Calcitonin Gene-Related Peptide / Q000502:physiology; D005123:Eye / Q000276:immunology*; D053222:Fas Ligand Protein; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007108:Immune Tolerance / Q000276:immunology*; D007371:Interferon-gamma / Q000276:immunology; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000276:immunology; D008262:Macrophage Activation; D008562:Membrane Glycoproteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000502:physiology; D014660:Vasoactive Intestinal Peptide / Q000502:physiology; D000521:alpha-MSH / Q000502:physiology; D019014:fas Receptor / Q000276:immunology
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008222:Lymphokines; D008562:Membrane Glycoproteins; D016212:Transforming Growth Factor beta; D019014:fas Receptor; D014660:Vasoactive Intestinal Peptide; D000521:alpha-MSH; D007371:Interferon-gamma; D015740:Calcitonin Gene-Related Peptide